ADH-6 TFA
ADH-6 TFA is a tripyridylamide compound that targets and dissociates mutant p53 aggregates in cancer cells. By disrupting the aggregation-nucleating subdomain, it reactivates p53 transcriptional function, leading to cell cycle arrest and apoptosis. This mechanism supports its application in cancer research, including in vitro studies on p53-aggregation related oncogenesis.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation; Metabolism Research
Molecular Formula
C31H37F3N8O11
Molecular Weight
754.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
037627-ML550 100 µL
KRT7, NT (KRT7, SCL, Keratin, type II cytoskeletal 7, Cytokeratin-7, Keratin-7, Sarcolectin, Type-II keratin Kb7) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
K1979606 1.0 µg DNA
RPL36AP10 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details orb2919376-01 20 µg
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_1462 (AF_1462)
Sign In for Pricing
View Details 
orb2919376-02 100 µg
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_1462 (AF_1462)
Sign In for Pricing
View Details